Tortoise Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10
Closed -$1.15K 885
2024
Q3
$1.15K Buy
+10
New +$1.14K ﹤0.01% 808
2024
Q2
Sell
-26
Closed -$2.52K 900
2024
Q1
$2.52K Buy
+26
New +$2.67K ﹤0.01% 749
2016
Q3
Sell
-195
Closed -$14K 495
2016
Q2
$14K Buy
195
+95
+95% +$6.56K ﹤0.01% 278
2016
Q1
$7K Sell
100
-84
-46% -$5.71K ﹤0.01% 312
2015
Q4
$14K Buy
184
+84
+84% +$6.67K 0.01% 288
2015
Q3
$8K Hold
100
﹤0.01% 306
2015
Q2
$9K Hold
100
﹤0.01% 321
2015
Q1
$9K Buy
+100
New +$8.87K ﹤0.01% 302
2014
Q3
Sell
-558
Closed -$45K 418
2014
Q2
$45K Buy
+558
New +$43.9K 0.02% 214

Other funds holding NVS

Tortoise Investment Management's NVS Position: Q4 2024 in Review

Tortoise Investment Management sold out of Novartis (NVS) in Q4 2024, closing a stake of 10 shares — an estimated $1.15K sold.

Tortoise Investment Management first reported a position in NVS in Q2 2014 and held it in 9 quarters. The position peaked at $45K in Q2 2014. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • Tortoise Investment Management reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
  • Tortoise Investment Management sold 10 Novartis shares in Q4 2024, an estimated $1.15K.
  • Tortoise Investment Management first reported a position in Novartis in Q2 2014 and held it in 9 quarters.
  • Tortoise Investment Management's Novartis position peaked at $45K in Q2 2014.
  • 1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Tortoise Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.